Boehringer Ingelheim

Encephalomyelitis-West Nile Virus Vaccine

Eastern & Western & Venezuelan, Killed Virus

Tetanus Toxoid

Indications:

For the vaccination of healthy horses 6 months of age or older as an aid in the prevention of diseases caused by Eastern, Western, and Venezuelan Encephalomyelitis, tetanus, and viremia caused by West Nile Virus. Duration of immunity studies are in progress.

Administration and Dosage:

Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure with a single 1 mL intramuscular dose.

Precautions:

Store at 35-45°F (2-7°C). Protect from freezing. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur following use. Antidote: Epinephrine.

Preservative:

Gentamicin

This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy in normal, healthy, immunocompetent animals. This level of performance may be affected by conditions such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies, or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.